5 High Growth Value Stocks to Invest in According to Seth Klarman

4. Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Number of Q4 2023 Hedge Fund Shareholders: 42

Average 3-Year Revenue Growth Rate: 17.5%

Baupost Group’s Q4 2023 Stake: $102 million

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is a biotechnology company headquartered in Dublin, Ireland. The shares are rated Strong Buy on average, and the average share price target is $189.

As of December 2023 end, 42 out of the 933 hedge funds tracked by Insider Monkey had held a stake in the firm. The largest Jazz Pharmaceuticals plc (NASDAQ:JAZZ) hedge fund shareholder is Bernard Horn’s Polaris Capital Management through its $155.8 million investment.

Follow Jazz Pharmaceuticals Plc (NASDAQ:JAZZ)